In the GBM-SCs studied by us, FoxO1 shRNA knockdown only slightly reduced proliferation and expression of the stem and progenitor cell markers Sox2 and Nestin; statistical significance was only reached for GBM22 (Figures 4A, 4D and S4). The gene discussed is SOX2; the disease is glioblastoma.